American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use

Lead Story: Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use

Tuesday 24th May 2022

Compare Buprenorphine and Naltrexone for opioid use disorder and explore various addiction treatment challenges on 'Addiction Medicine Unpacked'.
7 minutes
Informative
Educational
Thought-provoking
Engaging
Transformative

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Buprenorphine vs. Naltrexone: A Deep Dive into Opioid Use Disorder Treatments

These findings suggest that individuals with co-occurring SUDs were less likely to receive buprenorphine, despite Buprenorphine's Association with overdose protection.
Ever wondered why some treatments for opioid use disorder are preferred over others? This episode of 'Addiction Medicine Unpacked' takes you through a comprehensive study comparing Buprenorphine and Naltrexone. With a sample size of 179,280 individuals, the findings reveal that people with co-occurring substance use disorders are less likely to receive Buprenorphine, even though it's known for its overdose protection benefits. So, why the disparity?
The episode explores the barriers to prescribing Buprenorphine and offers recommendations for treating substance use disorders, especially during the COVID-19 pandemic. But that's not all. The podcast also touches on other pressing issues like stimulant use and driving under the influence, the rise of tobacco-free nicotine products, and efforts to prevent gambling harm. Plus, it delves into the stigma surrounding alcohol-related liver disease.
Hosted by Claire Rasmussen, this episode promises to leave you with a richer understanding of the complexities and challenges in addiction medicine today. If you're looking for an episode packed with vital information and real-world applications, this one's for you.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.